224 related articles for article (PubMed ID: 25918673)
21. Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients.
Börjesson PK; Jauw YW; de Bree R; Roos JC; Castelijns JA; Leemans CR; van Dongen GA; Boellaard R
J Nucl Med; 2009 Nov; 50(11):1828-36. PubMed ID: 19837762
[TBL] [Abstract][Full Text] [Related]
22.
Sato N; Stringaris K; Davidson-Moncada JK; Reger R; Adler SS; Dunbar C; Choyke PL; Childs RW
Clin Cancer Res; 2020 Jun; 26(11):2573-2581. PubMed ID: 32034075
[TBL] [Abstract][Full Text] [Related]
23. Simplified
Polyak A; Bankstahl JP; Besecke KFW; Hozsa C; Triebert W; Pannem RR; Manstein F; Borcholte T; Furch M; Zweigerdt R; Gieseler RK; Bengel FM; Ross TL
Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371788
[TBL] [Abstract][Full Text] [Related]
24. CD4
Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
[TBL] [Abstract][Full Text] [Related]
25. In Vivo PET Tracking of
Man F; Lim L; Volpe A; Gabizon A; Shmeeda H; Draper B; Parente-Pereira AC; Maher J; Blower PJ; Fruhwirth GO; T M de Rosales R
Mol Ther; 2019 Jan; 27(1):219-229. PubMed ID: 30429045
[TBL] [Abstract][Full Text] [Related]
26. A kit formulation for the preparation of [
Man F; Khan AA; Carrascal-Miniño A; Blower PJ; T M de Rosales R
Nucl Med Biol; 2020; 90-91():31-40. PubMed ID: 32979725
[TBL] [Abstract][Full Text] [Related]
27. Feasibility of real-time in vivo 89Zr-DFO-labeled CAR T-cell trafficking using PET imaging.
Lee SH; Soh H; Chung JH; Cho EH; Lee SJ; Ju JM; Sheen JH; Kim H; Oh SJ; Lee SJ; Chung J; Choi K; Kim SY; Ryu JS
PLoS One; 2020; 15(1):e0223814. PubMed ID: 31910217
[TBL] [Abstract][Full Text] [Related]
28. [(89)Zr]oxinate4 for long-term in vivo cell tracking by positron emission tomography.
Charoenphun P; Meszaros LK; Chuamsaamarkkee K; Sharif-Paghaleh E; Ballinger JR; Ferris TJ; Went MJ; Mullen GE; Blower PJ
Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):278-87. PubMed ID: 25359636
[TBL] [Abstract][Full Text] [Related]
29. Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
Verel I; Visser GW; Boellaard R; Boerman OC; van Eerd J; Snow GB; Lammertsma AA; van Dongen GA
J Nucl Med; 2003 Oct; 44(10):1663-70. PubMed ID: 14530484
[TBL] [Abstract][Full Text] [Related]
30. Development and in vitro evaluation of new bifunctional
Klasen B; Lemcke D; Mindt TL; Gasser G; Rösch F
Nucl Med Biol; 2021; 102-103():12-23. PubMed ID: 34242949
[TBL] [Abstract][Full Text] [Related]
31.
Price EW; Carnazza KE; Carlin SD; Cho A; Edwards KJ; Sevak KK; Glaser JM; de Stanchina E; Janjigian YY; Lewis JS
J Nucl Med; 2017 Sep; 58(9):1386-1394. PubMed ID: 28280216
[TBL] [Abstract][Full Text] [Related]
32. ImmunoPET imaging of CD38 in murine lymphoma models using
Kang L; Jiang D; England CG; Barnhart TE; Yu B; Rosenkrans ZT; Wang R; Engle JW; Xu X; Huang P; Cai W
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1372-1381. PubMed ID: 29450576
[TBL] [Abstract][Full Text] [Related]
33. Immuno-PET Imaging of
Li D; Cheng S; Zou S; Zhu D; Zhu T; Wang P; Zhu X
Mol Pharm; 2018 Apr; 15(4):1674-1681. PubMed ID: 29502426
[TBL] [Abstract][Full Text] [Related]
34. Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants.
Meyer JP; Edwards KJ; Kozlowski P; Backer MV; Backer JM; Lewis JS
J Nucl Med; 2016 Nov; 57(11):1811-1816. PubMed ID: 27390161
[TBL] [Abstract][Full Text] [Related]
35. Phase I/IIa PET imaging study with
Joraku A; Hatano K; Kawai K; Kandori S; Kojima T; Fukumitsu N; Isobe T; Mori Y; Sakata M; Hara T; Nasu K; Minami M; Iizumi Y; Nishiyama H
Ann Nucl Med; 2019 Feb; 33(2):119-127. PubMed ID: 30406361
[TBL] [Abstract][Full Text] [Related]
36. A Distinct Advantage to Intraarterial Delivery of
Lesniak WG; Chu C; Jablonska A; Du Y; Pomper MG; Walczak P; Janowski M
J Nucl Med; 2019 May; 60(5):617-622. PubMed ID: 30315146
[TBL] [Abstract][Full Text] [Related]
37. Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images.
Jauw YWS; Heijtel DF; Zijlstra JM; Hoekstra OS; de Vet HCW; Vugts DJ; Verheul HM; Boellaard R; Zweegman S; van Dongen GAMS; der Houven van Oordt CWM; Lammertsma AA; Huisman MC
Mol Imaging Biol; 2018 Dec; 20(6):1025-1034. PubMed ID: 29713958
[TBL] [Abstract][Full Text] [Related]
38. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
Ni D; Jiang D; Ehlerding EB; Huang P; Cai W
Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335
[TBL] [Abstract][Full Text] [Related]
39. The pharmacokinetics of Zr-89 labeled liposomes over extended periods in a murine tumor model.
Seo JW; Mahakian LM; Tam S; Qin S; Ingham ES; Meares CF; Ferrara KW
Nucl Med Biol; 2015 Feb; 42(2):155-63. PubMed ID: 25451215
[TBL] [Abstract][Full Text] [Related]
40. Noninvasive Trafficking of Brentuximab Vedotin and PET Imaging of CD30 in Lung Cancer Murine Models.
Kang L; Jiang D; Ehlerding EB; Barnhart TE; Ni D; Engle JW; Wang R; Huang P; Xu X; Cai W
Mol Pharm; 2018 Apr; 15(4):1627-1634. PubMed ID: 29537283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
